Table 3.

AMCP‐type B technologies for which NHI coverage was not identified after study completion

No NHI or regulatory coverage after AMCP‐type B	17
High evaluation	2
Market approval in process	2
Intermediate evaluation	10
Shift to clinical trial framework driven by patient demand	1
“Special notification”	1
Move to another clinical trial: AMCP‐type B	3
Move to another clinical trial: IND trial	2
Move to another clinical trial: Other	3
Low evaluation	5

AMCP, Advanced Medical Care Program; IND, investigational new drug; NHI, National Health Insurance.